Trium Capital »

Kinnate Biopharma shares owned by Trium Capital

Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by Trium Capital from 13F filings

Historical chart of Trium Capital investment in Kinnate Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Kinnate Biopharma held by Trium Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kinnate Biopharma by Trium Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $312k 118k 2.66

More positions owned by Trium Capital

Kraneshares Csi China Intern Csi Chi Internet (KWEB)
Neogames Sa SHS (NGMS)
Pioneer Natural Resources (PXD)
Ishares China Large-cap Etf China Lg-cap Etf (FXI)
Kaman Corporation (KAMN)
Tricon Residential Com Npv (TCN)
Abbott Laboratories (ABT)
Otis Worldwide Corp (OTIS)
Vaneck Vietnam Etf Vaneck Vietnam (VNM)
Daseke (DSKE)
UnitedHealth (UNH)
Moody's Corporation (MCO)
Stryker Corporation (SYK)
Ecolab (ECL)
Cme (CME)

View all positions for Trium Capital

Top funds holding Kinnate Biopharma

Foresite Capital Management IV
OrbiMed Advisors
Foresite Capital Management V
Lynx1 Capital Management
Viking Global Investors
Susquehanna International
Vanguard Group
Deltec Asset Management
Tang Capital Management
Acadian Asset Management
BML Capital Management
Yakira Capital Management
BlackRock
Group One Trading
GSA Capital Partners

View all funds holding Kinnate Biopharma